Computational Modeling Toward Understanding Agonist Binding on Dopamine 3-Reference-Cited by-同舟云学术

Computational Modeling Toward Understanding Agonist Binding on Dopamine 3

Published:2010-08-09 Issue:9 Volume:50 Page:1633-1643
ISSN:1549-9596
Container-title:Journal of Chemical Information and Modeling
language:en
Short-container-title:J. Chem. Inf. Model.

Author:

Zhao Yaxue¹,Lu Xuefeng¹,Yang Chao-yie¹,Huang Zhimin¹,Fu Wei¹,Hou Tingjun¹,Zhang Jian¹

Affiliation:

1. Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China, Functional Nano & Soft Materials Laboratory (FUNSOM) and Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices, Soochow University, Suzhou, Jiangsu 215123, China, School of Pharmacy, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, China, Section of Molecular Biology, Division of...

Publisher

American Chemical Society (ACS)

Subject

Library and Information Sciences,Computer Science Applications,General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ci1002119

Reference65 articles.

1. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

2. Dopamine D3 receptor mRNA and binding sites in human brain

3. Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain.

4. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA

5. Dopamine D3 receptor agonists for protection and repair in Parkinson's disease

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Silico Repositioning of Dopamine Modulators with Possible Application to Schizophrenia: Pharmacophore Mapping, Molecular Docking and Molecular Dynamics Analysis;ACS Omega;2021-06-01

2. Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson’s Disease;Biomolecules;2019-04-09

3. Emerging targets and new small molecule therapies in Parkinson’s disease treatment;Bioorganic & Medicinal Chemistry;2016-04

4. Computational Study and Modified Design of Selective Dopamine D3Receptor Agonists;Chemical Biology & Drug Design;2016-03-09

5. Identification of key residues involved in the activation and signaling properties of dopamine D3 receptor;Pharmacological Research;2015-09